Clinical Trial Detail

NCT ID NCT02042989
Title MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lymphoma

Advanced Solid Tumor

Therapies

Ixazomib + Vorinostat

Age Groups: senior adult

No variant requirements are available.